Alessia Iannaccone

Statistics

Publications

Citations

496

H-Index

Active since

2012

Affiliations

Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"(Current)

Casa Sollievo della Sofferenza

Istituti di Ricovero e Cura a Carattere Scientifico

University of Naples Federico II

Ospedale Monaldi

Alessia Iannaccone is an author at Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale" specializing in oncology, molecular oncology, and medicine.

Publications per year

2012–2019

Publications

Heterogeneity of KRAS, NRAS, BRAF and PIK3CA mutations in metastatic colorectal cancer and potential effects on therapy in the CAPRI GOIM trial

Nicola Normanno, Anna Maria Rachiglio, Matilde Lambiase et al. · Annals of Oncology · 2015 · 146 citations · Full text

Medicine, Molecular Medicine, Oncology +17

RAS testing of liquid biopsy correlates with the outcome of metastatic colorectal cancer patients treated with first-line FOLFIRI plus cetuximab in the CAPRI-GOIM trial

Nicola Normanno, Riziero Esposito Abate, Matilde Lambiase et al. · Annals of Oncology · 2017 · 119 citations

Medicine, Oncology, Pathology +17

Molecular diagnostics and personalized medicine in oncology: Challenges and opportunities

Nicola Normanno, Anna Maria Rachiglio, Cristin Roma et al. · Journal of Cellular Biochemistry · 2012 · 70 citations

Medicine, Molecular Medicine, Oncology +17

The S492R EGFR ectodomain mutation is never detected in KRAS wild-type colorectal carcinoma before exposure to EGFR monoclonal antibodies

Claudia Esposito, Anna Maria Rachiglio, Maria Libera La Porta et al. · Cancer Biology & Therapy · 2013 · 54 citations · Full text

Medicine, Molecular Biology, Oncology +17

Genomic Profiling of KRAS/NRAS/BRAF/PIK3CA Wild-Type Metastatic Colorectal Cancer Patients Reveals Novel Mutations in Genes Potentially Associated with Resistance to Anti-EGFR Agents

Anna Maria Rachiglio, Matilde Lambiase, Francesca Fenizia et al. · Cancers · 2019 · 44 citations · Full text

Medicine, Molecular Genetics, Oncology +17

1–5 of 7